What is peptide synthesis?

Peptide synthesis is the chemical process of creating peptides, which are short chains of amino acids linked together by peptide bonds.

How big is the Peptide Synthesis Market?

The global Peptide Synthesis Market size was estimated at USD 602.3 Million in 2023 and is expected to reach USD 1312.4 Million in 2033.

What is the Peptide Synthesis Market growth?

The global Peptide Synthesis Market is expected to grow at a compound annual growth rate of 8.1%. From 2024 To 2033

Who are the key companies/players in the Peptide Synthesis Market?

Some of the key players in the Peptide Synthesis Markets are Lonza, MP Biomedicals, Novo Nordisk A/S., Genscript Biotech, CEM Corporation, Thermo Fisher, Creative Diagnostics, Polypeptide Group, Syngene, PuroSynth, Merck KGaA, Bachem Holdings, Biotage.

What are peptides used for?

Peptides have various applications, including drug discovery, therapeutic development, diagnostics, and research in fields such as pharmaceuticals, biotechnology, and academia.

What factors drive the growth of the peptide synthesis market?

Market growth is driven by increasing demand for peptide-based therapeutics, advancements in peptide synthesis technology, rising prevalence of chronic diseases, and expanding applications in drug discovery and diagnostics.

What are the main challenges faced by the peptide synthesis market?

Challenges include high production costs, complexity in scaling up synthesis processes, and the need for continuous innovation to meet evolving customer needs and regulatory requirements.

Global Peptide Synthesis Market By Product Type(Equipment, Reagents & Consumables, Other Product Types) By Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology) By Application-Therapeutics(Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) By Diagnosis, By Research, By End-use (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization/Contract Research Organization, Academic & Research Institutes) By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024–2033

Published date: Feb 2024
Report ID: 18814
Number of Pages: 393
Format:

- Lonza
- MP Biomedicals
- Novo Nordisk A/S.
- Genscript Biotech
- CEM Corporation
- Thermo Fisher
- Creative Diagnostics
- Polypeptide Group
- Syngene, PuroSynth
- Merck KGaA
- Bachem Holdings
- Biotage